0000914475-24-000080.txt : 20240229 0000914475-24-000080.hdr.sgml : 20240229 20240229185029 ACCESSION NUMBER: 0000914475-24-000080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240227 FILED AS OF DATE: 20240229 DATE AS OF CHANGE: 20240229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Norwalk Leslie V CENTRAL INDEX KEY: 0001533568 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 24706126 MAIL ADDRESS: STREET 1: C/O 3661 VALLEY CENTRE DRIVE SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330525145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 wk-form4_1709250595.xml FORM 4 X0508 4 2024-02-27 0 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001533568 Norwalk Leslie V 12780 EL CAMINO REAL SAN DIEGO CA 92130 1 0 0 0 1 Common Stock 2024-02-27 4 M 0 8000 84.95 A 8000 D Common Stock 2024-02-27 4 S 0 8000 135.6735 D 0 D Non-Qualified Stock Option 84.95 2024-02-27 4 M 0 8000 84.95 D 2032-05-18 Common Stock 8000 1724 D The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $134.82 to $136.50. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Option vests in 12 monthly installments beginning June 18, 2022. /s/ Darin Lippoldt, Attorney-in-Fact 2024-02-29